Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria
- PMID: 8122925
- DOI: 10.1080/00034983.1993.11812820
Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-inducing toxin of Plasmodium falciparum: prospects for the immunotherapy of severe malaria
Abstract
Tumour necrosis factor-alpha (TNF-alpha) is an endogenous mediator of shock and inflammation. Many of the life-threatening and severe pathologies associated with complicated and cerebral malaria are thought to result from the overproduction of this cytokine in response to agents of parasite origin. The identification and characterization of these agents may therefore provide the molecular basis for a detailed understanding of the disease process. Recently it has been shown that glycosylphosphatidylinositols are a novel class of glycolipid toxin produced by the parasite, which substitute for the endogenous inositolglycan-based signal transduction pathways of the host. Glycosylphosphatidylinositol stimulates high levels of TNF-alpha and interleukin-1 production by macrophages and induces hypoglycaemia through an insulin-mimetic activity, and may therefore contribute to the cerebral syndrome and other malarial pathophysiology. That monoclonal antibodies to parasite-derived glycosylphosphatidylinositol can neutralize the toxic activities of whole parasite extracts is also demonstrated here. These findings suggest a central role for glycosylphosphatidylinositol of parasite origin in the aetiology of severe malaria and suggest novel approaches for the immunotherapy or immunoprophylaxis of disease.
Similar articles
-
Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.J Exp Med. 1993 Jan 1;177(1):145-53. doi: 10.1084/jem.177.1.145. J Exp Med. 1993. PMID: 8418196 Free PMC article.
-
Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway.J Immunol. 1996 Mar 1;156(5):1897-1907. J Immunol. 1996. PMID: 8596042
-
Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction.J Immunol. 1996 Mar 1;156(5):1886-96. J Immunol. 1996. PMID: 8596041
-
Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum.Microbes Infect. 2002 Jul;4(9):983-90. doi: 10.1016/s1286-4579(02)01619-2. Microbes Infect. 2002. PMID: 12106792 Review.
-
Rational approaches to developing an anti-disease vaccine against malaria.Microbes Infect. 2007 May;9(6):784-91. doi: 10.1016/j.micinf.2007.02.010. Epub 2007 Feb 21. Microbes Infect. 2007. PMID: 17434329 Review.
Cited by
-
Cytokines in the pathogenesis of and protection against malaria.Clin Diagn Lab Immunol. 2002 Nov;9(6):1145-52. doi: 10.1128/cdli.9.6.1145-1152.2002. Clin Diagn Lab Immunol. 2002. PMID: 12414742 Free PMC article. Review. No abstract available.
-
Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).Malar J. 2011 Oct 24;10:314. doi: 10.1186/1475-2875-10-314. Malar J. 2011. PMID: 22024312 Free PMC article.
-
Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.Biochemistry. 2018 Feb 6;57(5):516-519. doi: 10.1021/acs.biochem.7b01099. Epub 2018 Jan 16. Biochemistry. 2018. PMID: 29323879 Free PMC article.
-
Leukogram Profile and Clinical Status in vivax and falciparum Malaria Patients from Colombia.J Trop Med. 2015;2015:796182. doi: 10.1155/2015/796182. Epub 2015 Nov 18. J Trop Med. 2015. PMID: 26664413 Free PMC article.
-
Fatty acids isolated from Toxoplasma gondii reduce glycosylphosphatidylinositol-induced tumor necrosis factor alpha production through inhibition of the NF-kappaB signaling pathway.Infect Immun. 2007 Jun;75(6):2886-93. doi: 10.1128/IAI.01431-06. Epub 2007 Mar 26. Infect Immun. 2007. PMID: 17387164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources